AARON K COMPTON

Allopathic & Osteopathic Physicians|Pain Medicine|Interventional Pain Medicine LOUISVILLE, KY NPI 1609918879

General Payments — all program years on this page

$3,688.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 110
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $595.27 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $595.2720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,178.6422
2019 $373.0713
2020 $713.5014
2021 $314.0021
2022 $180.369
2023 $333.2511
2024 $595.2720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092482955 Boston Scientific Corporation $159.17 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105904482 VERTEX PHARMACEUTICALS INCORPORATED $17.33 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120054266 SI-BONE, INC. $25.15 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120057205 SI-BONE, INC. $19.39 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120059190 SI-BONE, INC. $25.89 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151514 Abbott Laboratories $13.81 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151516 Abbott Laboratories $33.97 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151518 Abbott Laboratories $12.91 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151520 Abbott Laboratories $5.63 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151522 Abbott Laboratories $33.05 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151524 Abbott Laboratories $8.38 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151526 Abbott Laboratories $8.57 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151528 Abbott Laboratories $16.37 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125151530 Abbott Laboratories $35.50 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130778699 Nevro Corp. $111.34 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130778701 Nevro Corp. $9.64 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130778703 Nevro Corp. $6.44 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130778705 Nevro Corp. $9.30 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133422378 Averitas Pharma Inc. $22.66 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136235239 SCILEX PHARMACEUTICALS INC. $20.77 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.